glp-1 factory German CDMO outlays $980m on manufacturing expansion GLP-1 Peptide Expansion Investment of

Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes (marketed as Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (marketed as Zepbound)

Interestingly, a recent MRI study comparing bipolar depressed with euthymic patients discovered decreased gray-matter volume of dorsomedial PFC and dorsolateral PFC (144)

reduction in fine lines

Wellness Rewards incentivizes Medicare members to complete specific health-related activities to earn rewards dollars on a reloadable flexible spending card

Everybody thinks its Ozempic, but its not